ZTS

AI Research

Zoetis Acquires Neogen Animal Genomics for $160M → 2026 Revenue Guided $9.825-10.025B

Zoetis will acquire Neogen Corporation's animal genomics business for $160 million to enhance precision animal health capabilities, with CEO participating in KeyBanc Healthcare Forum on March 17. Full-year 2025 revenue reached $9.5 billion with 6% organic growth, with 2026 guidance of $9.825–$10.025B and adjusted EPS of $7.00–$7.10. Stock trades at $115.62 with a Q2 2026 dividend of $0.53 per share, though US clinical visit growth expected to decline 2%.